2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox
CAS-Nr.
1093279-77-6
Englisch Name:
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox
Synonyma:
Mixed dimer;Mixed-POC DiMer;Tenofov Mixed Dimer;Tenofovir Impurity 153;Tri-POC Tenofovir DiMer;Tri-POC Tenofovir Dimer (>Tri-POC Tenofovir Dimer (>90%);Tenofovir Ester WHO Impurity I;Tenofovir disoproxil Impurity S;Tenofovir disoproxil Impurity F
CBNumber:
CB02655372
Summenformel:
C34H52N10O17P2
Molgewicht:
934.78
MOL-Datei:
1093279-77-6.mol
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox Eigenschaften
Schmelzpunkt:
66-74°C
Siedepunkt:
994.6±75.0 °C(Predicted)
Dichte
1.52±0.1 g/cm3(Predicted)
storage temp.
Hygroscopic, -20°C Freezer, Under Inert Atmosphere
L?slichkeit
Methanol (Slightly)
pka
1.87±0.10(Predicted)
Aggregatzustand
Solid
Farbe
White to Pale Beige
Stabilit?t:
Very Hygroscopic
Sicherheit
Risiko- und Sicherheitserkl?rung
Gefahreninformationscode (GHS)
Bildanzeige (GHS)
Alarmwort
Warnung
Gefahrenhinweise
Code
Gefahrenhinweise
Gefahrenklasse
Abteilung
Alarmwort
Symbol
P-Code
H302
Gesundheitssch?dlich bei Verschlucken.
Akute Toxizit?t oral
Kategorie 4
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P270, P301+P312, P330, P501
H315
Verursacht Hautreizungen.
Hautreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P302+P352, P321,P332+P313, P362
H319
Verursacht schwere Augenreizung.
Schwere Augenreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P305+P351+P338,P337+P313P
H335
Kann die Atemwege reizen.
Spezifische Zielorgan-Toxizit?t (einmalige Exposition)
Kategorie 3 (Atemwegsreizung)
Warnung
src="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261
Einatmen von Staub vermeiden.
P305+P351+P338
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox Chemische Eigenschaften,Einsatz,Produktion Methoden
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 65)Lieferanten
Canada 1
China 55
India 4
United States 5
Global 65
1093279-77-6()Verwandte Suche:
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-ox
Mixed-POC DiMer
Tri-POC Tenofovir DiMer
Mixed dimer
Tenofov Mixed Dimer
((((((R)-1-(6-((((9-((R)-2-((bis(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)methoxy)propyl)-9H-purin-6-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)(hydroxy)phosphoryl)oxy)methyl isopropyl carbonate
Tenofovir Disoproxil Fumarate impurity M
Tenofovir disoproxil Impurity F
Tenofovir disoproxil Impurity S
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-diMethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]aMino]Methyl]aMino]-9H-purin-9-yl]-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-o
Tenofovir Mixed Disoproxil Dimer
Tenofovir disoproxil impurity 3
Tenofovir impurity 7/Tri-POC Tenofovir Dimer/5-[[(1R)-2-[6-[[[[9-[(2R)-5-Hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedio
Tenofovir Disoproxil Impurity I(IP)
Tri-POC Tenofovir Dimer (>
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide
Tenofovir Disoproxil Fumarate IP Impurity I
Tri-POC Tenofovir Dimer (>90%)
Tenofovir Ester WHO Impurity I
((((((2R)-1-(6-((((9-((2R)-2-((hydroxy(((isopropoxycarbonyl)oxy)methoxy)phosphoryl)methoxy)propyl)-9H-purin-6-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl bis(carbonate)
Tenofovir Disoproxil Impurity I(IP)(a dimer)
5-[[(1R)-2-[6-[[[[9-[(2R)-5-Hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic Acid 1,9-Bis(1-methylethyl) Ester 5-Oxide
2-hydroxy-38-(methylthio)butanamide
Tenofovir Impurity 153
1093279-77-6
C34H52N10O17P2